Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
165.10
+11.20 (7.28%)
Oct 14, 2026, 4:08 PM HKT

HKG:2637 Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, HKG:2637 stock has a consensus rating of "Strong Buy" and an average price target of $292.71. The average 1-year stock price forecast is 77.29% higher than the current stock price, while the lowest is $280.48 (+69.88%) and the highest is $304.95 (+84.71%).

Price Target: $292.71 (+77.29%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$280.48$292.71$292.71$304.95
Change+69.88%+77.29%+77.29%+84.71%

Analyst Ratings

The average analyst rating for HKG:2637 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingApr '26Jun '26Sep '26Oct '26
Strong Buy1222
Buy0001
Hold0000
Sell0000
Strong Sell0000
Total1223

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
CMB International Securities
CMB International Securities
Buy
Maintains
$280.00
BuyMaintains$280.00+69.59%Sep 19, 2026
Unknown Analyst
SDIC Securities
No rating
SDIC Securities
Buy
Maintains
$266.80
BuyMaintains$266.80+61.60%Sep 9, 2026
Unknown Analyst
Guohai Securities
No rating
Guohai Securities
Buy
Maintains
$339.55
BuyMaintains$339.55+105.66%Sep 1, 2026
Unknown Analyst
Guotai Haitong
No rating
Guotai Haitong
Buy
Maintains
$298.99
BuyMaintains$298.99+81.10%Jul 3, 2026
Unknown Analyst
Huafu Securities
No rating
Huafu Securities
Buy
Maintains
$264.30
BuyMaintains$264.30+60.08%Jun 14, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
678.00M
from 582.36M
Increased by 16.42%
Revenue Next Year
774.00M
from 678.00M
Increased by 14.16%
EPS This Year
2.46
EPS Next Year
2.80
from 2.46
Increased by 14.05%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
212.47M316.63M466.68M582.36M678.00M
Revenue Growth
-49.03%47.39%24.79%16.42%
Gross Profit
172.07M263.64M387.19M485.56M555.96M
Gross Margin
80.99%83.26%82.97%83.38%82.00%
Operating Income
80.35M120.28M133.03M192.26M207.50M
Net Income
68.98M117.45M136.08M177.03M178.00M
EPS
----2.46
Forward PE
----57.35
Free Cash Flow
----97.00M
No. Analysts
----3
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High751.0M
Avg678.0M
Low629.0M

Revenue Growth

Revenue Growth202620272028
High
29.0%
Avg
16.4%
Low
8.0%

EPS Forecast

EPS202620272028
High2.52
Avg2.46
Low2.39

EPS Growth

EPS Growth20272028
High
15.3%
Avg
14.1%
Low
12.8%